Lung cancer is a serious disease. It is important to understand the choices people make when dealing with it. Non-small cell lung cancer is the most common type. So, what matters most to patients, their supporters, and doctors when they make treatment choices? There are many aspects to consider. Patients have their own priorities. They often want treatments that wi...
Lung cancer is a significant health issue, and non-small cell lung cancer (NSCLC) is a common type. One way to fight it is by targeting something called PD-L1, which is often found on lung cancer cells. Blocking PD-L1 can help the body's immune system attack the cancer. This is where aptamers come in. Aptamers are like tiny, smart molecules that can stick to specific...
Lung cancer is a tricky beast. It often hides from the immune system, making it tough to treat. But there's a glimmer of hope. Some lung cancers have a high number of mutations, which should make them easier for the immune system to spot. These are called TMB-H cancers. However, about 30% of these cancers are immune-desert tumors. This means they lack the necessary T...
Lung cancer is a formidable foe, but some people manage to outsmart it. Dukhi Hong, an 84-year-old woman from Utah, is one of those rare individuals who have defied the odds. She was given a grim prognosis in 2019 when doctors diagnosed her with aggressive small cell lung cancer. This type of cancer is notorious for its rapid spread and low survival rates. Her family...
In Brazil, the diagnosis of non-small cell lung cancer often comes too late. This delay pushes up the price of treatment. The financial burden of treating this disease in private healthcare settings is a growing concern. The cost of treating lung cancer can be astronomical. This is especially true when the disease is caught at an advanced stage. In these cases, the ...
In France, patients with advanced or metastatic non-small cell lung cancer (LAM NSCLC) have been given nivolumab as a second-line or later treatment. This drug is part of a group known as immune checkpoint inhibitors, which help the body's immune system fight cancer. The study focused on how patients were treated and what happened to them after receiving nivolumab. ...
Lung cancer is a serious disease that affects many people. In Norway, researchers looked into how different types of advanced non-squamous non-small cell lung cancer (NSCLC) are treated. They focused on patients with specific genetic changes: EGFR+, ALK+, and ROS1+. These genetic changes can make a big difference in how the cancer responds to treatment. The study tr...
Lung cancer is a massive problem worldwide. It is a leading cause of death. NSCLC, or non-small cell lung cancer, makes up a huge portion of these cases. Most people find out they have it when it is too late. This makes it hard to treat. The good news is, there might be a new way to fight it. Flavonoids are found in many foods we eat every day. These include f...
Pulmonary sarcomatoid carcinoma (PSC) is an unusual kind of lung cancer that quickly spreads and invades tissues. Typically, it's found at later stages, making surgery challenging. There's no clear best treatment for advanced PSC. Researchers looked at how well chemotherapy and immunotherapy-based treatments work for these patients. Researchers used data from the SE...
Heart health matters, especially for lung cancer patients undergoing radiation therapy. Since a big study called RTOG 0617, doctors have been paying more attention to how radiation affects the heart. But there's a problem: we don't have enough large-scale studies that accurately map the different parts of the heart. This lack of mapping makes it hard to understand ho...